![Efthymios Deliargyris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 88 113 $ per 2026-09-30
Efthymios N.
Deliargyris is currently Chief Medical Officer at CytoSorbents Corp.
since 2020.
Formerly, served as Chief Medical Officer at PLx Pharma, Inc. from 2018 to 2020, Director-Cardiology & Interventional Cardiology at Athens Medical Center SA from 2004 to 2010, and Assistant Professor at Wake Forest University from 2001 to 2004.
Education includes a doctorate from National & Kapodistrian University of Athens.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CYTOSORBENTS CORPORATION 0,72 % | 2026-06-01 | 22 593 ( 0,72 % ) | 88 113 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| CYTOSORBENTS CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | 2020-05-01 |
| Företag | Position | Slut |
|---|---|---|
| PLX PHARMA WINDDOWN CORP. | Teknisk/Vetenskaplig/F&U Direktör | 2020-04-30 |
| ATHENS MEDICAL C.S.A. | Företagsledare/Principal | 2010-01-01 |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2004-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Athens Medical Center SA
 Athens Medical Center SA Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National & Kapodistrian University of Athens
 National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoSorbents Corp.
 CytoSorbents Corp. Medical SpecialtiesHealth Technology Develops products to support healthcare professionals in the treatment of complex medical conditions | Health Technology |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops liquid-filled aspirin capsules for pain management | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
